Why the UK was faster than US is race to approve Pfizer vaccine
Anthony Fauci apologises after suggesting Britain’s regulator ‘rushed’ process of assessing Covid jab

America’s top infectious diseases expert has apologised after apparently criticising the speed with which the UK approved the Pfizer vaccine to become the world’s first country to green-light the Covid immunity jab.
Dr Anthony Fauci, who heads the US National Institute of Allergy and Infectious Diseases, told CBS News yesterday that Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) had “really rushed through that approval”.
“I do have great faith in both the scientific community and the regulatory community in the UK,” Fauci continued. “I have a great deal of confidence in what the UK does both scientifically and from a regulatory standpoint.”
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The US medical chief held out the olive branch after the MHRA issued a statement insisting that it “rigorously assessed the data in the shortest time possible, without compromising the thoroughness of our review”.
The medicines regulator - which formally approved the Pfizer/BioNTech-developed jab on Wednesday - said its experts had reviewed preliminary data on the vaccine trials dating back to June and had been running a “rolling review” since October, helping to speed up the process.
The race to roll out a vaccine has generated “an extraordinary bout of global sniping”, with critics in both the US and European “taking aim at the MHRA for the speed with which it granted the vaccine an emergency authorisation”, The Times reports.
Experts say that the differences in approval timescales is down to “the US, EU and UK regulators [having] different styles”, the paper continues.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
“While the Americans rerun the safety and efficacy analyses performed by drugmakers, the EU and UK check the analyses, which can be quicker.”
Fauci claims another reason for the US lagging behind is the strength of the opposition from anti-vaccination activists in the country. He told CBS: “If we had jumped over the hurdle here quickly and inappropriately to gain an extra week or a week and a half, I think that the credibility of our regulatory process would have been damaged.”
-
Marisa Silver’s 6 favorite books that capture a lifetime
Feature The author recommends works by John Williams, Ian McEwan, and more
-
Book reviews: ‘We the People: A History of the U.S. Constitution’ and ‘Will There Ever Be Another You’
Feature The many attempts to amend the U.S. Constitution and Patricia Lockwood’s struggle with long Covid
-
Philadelphia’s Calder Gardens
Feature A permanent new museum
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA